Furthermore, in the context of targeting ERK5 by PROTACs in melanoma or PDAC, careful consideration should be given to seeking an E3 ligase that exhibits selective expression in melanoma or PDAC to mitigate possible on-target toxicity in other tissues. Here, MAPK7 is linked to melanoma.